Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration
Disease Models & Mechanisms · 01.04.2025 · 18 (4)
DOI: 10.1242/dmm.052057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 29.04.2025. Verfasst von Mikiko Oka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Tokyo Metropolitan University, Tokyo 192-0397, Japan. Hauptthemen laut MEDLINE: Glucose, Neuroglia, tau Proteins, Retinal Degeneration. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baylor College of Medicine, National Institute of Genetics, Japan Society for the Promotion of Science London.
Abstract (Originalsprache)
Brain inflammation contributes to the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease (AD). Glucose hypometabolism and glial activation are pathological features seen in AD brains; however, the connection between the two is not fully understood. Using a Drosophila model of AD, we identified that glucose metabolism in glia plays a critical role in neuroinflammation under disease conditions. Expression of human MATP (hereafter referred to as Tau) in the retinal cells, including photoreceptor neurons and pigment glia, causes photoreceptor degeneration accompanied by the formation of dark-stained round inclusion-like structures and swelling of the lamina cortex. We found that inclusion-like structures are formed by glial phagocytosis, and swelling of the laminal cortex correlates with the expression of antimicrobial peptides. Coexpression of human glucose transporter 3 (SLC2A3, hereafter referred to as GLUT3) with Tau in the retina does not affect Tau levels but suppresses these inflammatory responses and photoreceptor degeneration. We also found that expression of GLUT3, specifically in the pigment glia, is sufficient to suppress inflammatory phenotypes and mitigate photoreceptor degeneration in the Tau-expressing retina. Our results suggest that glial glucose metabolism contributes to inflammatory responses and neurodegeneration in tauopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Tokyo Metropolitan University, Tokyo 192-0397, Japan.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
- Jan and Dan Duncan Neurological Research Institute for Texas Children's Hospital, Houston, TX 77030, USA.
ORCID-Profile: Kanae Ando
Förderung
- Baylor College of Medicine
- National Institute of Genetics
- Japan Society for the Promotion of Science London
- Tokyo Metropolitan University
- Japan Society for the Promotion of Science (JSPS)
- Harvard University
- NIH HHS
- NIA NIH HHS
Zitieren
APA
Oka, M., Nakajima, S., Suzuki, E., Yamamoto, S., & Ando, K. (2025). Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration. Disease Models & Mechanisms, 18(4). https://doi.org/10.1242/dmm.052057
Vancouver
Oka M, Nakajima S, Suzuki E, Yamamoto S, Ando K. Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration. Disease Models & Mechanisms. 2025;18(4). doi:10.1242/dmm.052057
BibTeX
@article{Oka2025,
author = {Oka, Mikiko and Nakajima, Sho and Suzuki, Emiko and Yamamoto, Shinya and Ando, Kanae},
title = {Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration},
journal = {Disease Models & Mechanisms},
year = {2025},
volume = {18},
number = {4},
doi = {10.1242/dmm.052057}
}
EUVIMED